| Literature DB >> 22933873 |
Christina Teeter Doligalski1, Angela Tong Logan, Andrew Silverman.
Abstract
One of the most clinically significant complications related to the use of pharmacotherapy is the potential for drug-drug or drug-disease interactions. The gastrointestinal system plays a large role in the pharmacokinetic profile of most medications, and many medications utilized in gastroenterology have clinically significant drug interactions. This review will discuss the impact of alterations of intestinal pH, interactions mediated by phase I hepatic metabolism enzymes and P-glycoprotein, the impact of liver disease on drug metabolism, and interactions seen with commonly utilized gastrointestinal medications.Entities:
Keywords: Drug interaction; cirrhosis; cytochrome P450 enzyme; macrolides; prokinetic agents; protease inhibitors
Year: 2012 PMID: 22933873 PMCID: PMC3424472
Source DB: PubMed Journal: Gastroenterol Hepatol (N Y) ISSN: 1554-7914